EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The accuracy of reverse genetics systems for SARS‐CoV‐2: Circular polymerase extension reaction versus bacterial artificial chromosome

Yuri Furusawa iD, Seiya Yamayoshi iD, Yoshihiro Kawaoka

Influenza and Other Respiratory Viruses · 2023

DOI: 10.1111/irv.13109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2023. Verfasst von Yuri Furusawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Virology, Institute of Medical Science University of Tokyo Tokyo Japan. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reverse genetics systems to rescue viruses from modified DNA are useful tools to investigate the molecular mechanisms of viruses. The COVID‐19 pandemic prompted the development of several reverse genetics systems for SARS‐CoV‐2. The circular polymerase extension reaction (CPER) method enables the rapid generation of recombinant SARS‐CoV‐2; however, such PCR‐based approaches could introduce unwanted mutations due to PCR errors.

Methods

To compare the accuracy of CPER and a classic reverse genetics method using bacterial artificial chromosome (BAC), SARS‐CoV‐2 Wuhan/Hu‐1/2019 was generated five times using BAC and five times using CPER. These 10 independent virus stocks were then deep sequencing, and the number of substitutions for which the frequency was greater than 10% was counted.

Results

No nucleotide substitutions with a frequency of greater than 10% were observed in all five independent virus stocks generated by the BAC method. In contrast, three to five unwanted nucleotide substitutions with a frequency of more than 10% were detected in four of the five virus stocks generated by the CPER. Furthermore, four substitutions with frequencies greater than 20% were generated in three virus stocks by using the CPER.

Conclusions

We found that the accuracy of the CPER method is lower than that of the BAC method. Our findings suggest care should be used when employing the CPER method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansChromosomes, Artificial, BacterialPandemicsReverse Genetics

Stichwörter der Autor:innen

BACCPERSARS‐CoV‐2reverse genetics

Autor:innen und Institutionen

  • Division of Virology, Institute of Medical Science University of Tokyo Tokyo Japan.
  • The Research Center for Global Viral Diseases National Center for Global Health and Medicine Research Institute Tokyo Japan.
  • International Research Center for Infectious Diseases, Institute of Medical Science University of Tokyo Tokyo Japan.
  • Department of Pathobiological Sciences, School of Veterinary Medicine University of Wisconsin-Madison Madison Wisconsin USA.

ORCID-Profile: Yuri Furusawa, Seiya Yamayoshi

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Japan Agency for Medical Research and Development

Zitieren

APA

Furusawa, Y., Yamayoshi, S., & Kawaoka, Y. (2023). The accuracy of reverse genetics systems for SARS‐CoV‐2: Circular polymerase extension reaction versus bacterial artificial chromosome. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13109

Vancouver

Furusawa Y, Yamayoshi S, Kawaoka Y. The accuracy of reverse genetics systems for SARS‐CoV‐2: Circular polymerase extension reaction versus bacterial artificial chromosome. Influenza and Other Respiratory Viruses. 2023. doi:10.1111/irv.13109

BibTeX
@article{Furusawa2023,
  author = {Furusawa, Yuri and Yamayoshi, Seiya and Kawaoka, Yoshihiro},
  title = {The accuracy of reverse genetics systems for SARS‐CoV‐2: Circular polymerase extension reaction versus bacterial artificial chromosome},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2023},
  doi = {10.1111/irv.13109}
}
Kostenlos starten →